Novocure Ltd
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.2% | -10.9% | -22.8% | -1.1% | 6.7% | -2.1% | -23.0% | -10.0% | 12.3% | -10.3% | -7.8% | 6.8% | 0.2% | |
| 2.2% | 2.0% | 2.0% | 1.9% | 1.6% | 1.9% | -2.1% | 2.2% | -1.6% | 2.4% | 0.9% | 0.9% | 0.7% | |
| 20.7% | 13.0% | 24.6% | 21.2% | 20.2% | 38.9% | 19.1% | 16.5% | 17.5% | 11.4% | 36.2% | 9.3% | 18.5% | |
| 17.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 4.9% | 16.6% | -18.2% | 2.0% | 9.0% | 2.9% | -17.7% | -4.2% | 18.0% | -8.5% | -4.6% | 2.3% | 1.7% | |
| 5.7% | 5.1% | 8.5% | 7.6% | 6.9% | 5.5% | 6.8% | 3.5% | 3.4% | 2.8% | 3.0% | 3.8% | 3.2% | |
| 13.6% | 73.6% | 177.8% | -249.0% | 6.6% | -13.8% | -4.2% | 22.7% | 42.7% | 192.9% | 4.5% | -3.5% | 58.5% | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 59.8% | -321.7% | 0.0% | 0.0% | -65.9% | |
| 0.9% | 1.4% | 0.2% | 58.1% | 0.1% | 1.7% | 3.4% | 1.5% | 60.1% | -320.9% | -0.1% | 2.5% | -65.0% | |
| -0.8% | 64.3% | 155.1% | -192.2% | 13.4% | -14.3% | -23.7% | 14.3% | 115.1% | -138.4% | -3.5% | 5.8% | -6.3% | |
| -20.9% | -16.0% | -31.3% | -8.8% | -0.2% | -7.7% | -29.9% | -13.5% | 8.9% | -13.1% | -10.7% | 3.0% | -3.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.